美国联邦法院表示，恐怖组织“迈赫迪军”（Jaysh al-Mahdi）袭击的受害者可以继续推进针对大型药物和器械制造商的《反恐怖主义法》（ATA）辅助教唆指控。哥伦比亚特区巡回上诉法院发现，原告合理地指控了被告的参与是“有意识、自愿且有过错的”，并为“迈赫迪军”的行动提供了便利。原告指控21家公司向“迈赫迪军”支付非法贿赂以获取采购合同，这些资金资助了发生在伊拉克的袭击，导致美国公民死亡或永久残废。 法院裁定，原告有理有据地指控被告的参与是“有意识、自愿且有过错的”，并为“迈赫迪军”的行动提供了便利，且被告的援助与特定恐怖行为之间存在关联。“迈赫迪军”的受害者及其家属指控来自五个企业家族的21家公司——包括阿斯利康（AstraZeneca PLC）、通用电气医疗（GE Healthcare Technologies Inc.）、强生（Johnson & Johnson）、辉瑞（Pfizer Inc.）以及罗氏（F. Hoffman-La Roche Ltd.）——向该组织支付非法贿赂，以确保获得利润丰厚的采购合同。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.